tranont activate glp-1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Stay on track this summer

Glucose-tolerance and insulin-sensitivity measurements changed in obese mice

[3] [4] Simultaneously, GLP-1 suppresses glucagon secretion, slows gastric emptying, and sends satiety signals to the brain, helping you feel fuller for longer

Some of this can be attributed to changing habits that support better health and weight loss, but some shifts may be the result of the negative side-effects from the GLP-1s, including muscle loss and digestive issues

References Raun K, Hansen BS, Johansen NL, Thogersen H, Madsen K, Ankersen M, Andersen PH

Choose Injection Sites With Adequate Subcutaneous Tissue Injection sites with minimal subcutaneous fat, such as the inner thigh, the lower abdomen in leaner individuals, or areas close to bony prominences, offer less tissue cushioning between the needle and sensory nerve endings

Mol Neurobiol 61 , 63286340 (2024)